Smaller biotechs see new mechanisms of actions as future of obesity treatments
aprott Several small biotechs working on new treatments for weight loss believe that developing therapies
aprott Several small biotechs working on new treatments for weight loss believe that developing therapies
jetcityimage Eli Lilly (NYSE:LLY) and AdvanCell have agreed to work together on developing alpha therapies
Floortje Major stock indexes closed lower on Friday, after the week saw a flurry of
jetcityimage Eli Lilly (NYSE:LLY) reported positive results from an open-label study of its drug Omvoh
Earnings Call Insights: Eli Lilly and Company (NYSE:LLY) Q4 2024 Management View CEO David Ricks
jetcityimage/iStock Editorial via Getty Images Update 8.00 AM EST: Adds comments from Seeking Alpha analyst
Eli Lilly press release (NYSE:LLY): Q4 Non-GAAP EPS of $5.32 beats by $0.24. Revenue of
JHVEPhoto/iStock Editorial via Getty Images With its Q4 2024 results on Wednesday, Novo Nordisk (NVO)